Valuation: Implantica AG

Market Cap 1.51B 1.72B 1.4B 1.29B 2.42B 165B 2.45B 16.69B 6.52B 81.24B 6.44B 6.3B 281B P/E 2026 *
-16.7x
P/E 2027 * -14.4x
Enterprise Value 1.48B 1.69B 1.38B 1.27B 2.38B 162B 2.41B 16.39B 6.4B 79.8B 6.33B 6.19B 276B EV / Sales 2026 *
415x
EV / Sales 2027 * 165x
Free-Float
-
Yield 2026 *
-
Yield 2027 * -
1 day+0.85%
1 week+1.37%
Current month-3.10%
1 month-3.10%
3 months+25.85%
6 months+18.80%
Current year+18.56%
1 week 57.4
Extreme 57.4
60.5
1 month 57.4
Extreme 57.4
69
Current year 38
Extreme 38
69
1 year 38
Extreme 38
86.4
3 years 16
Extreme 16
86.4
5 years 15.4
Extreme 15.4
136.8
10 years 15.4
Extreme 15.4
178.9
Manager TitleAgeSince
Chief Executive Officer 72 2014-12-31
Director of Finance/CFO 48 2019-12-31
Corporate Officer/Principal 69 -
Director TitleAgeSince
Director/Board Member 71 2019-12-31
Chairman 67 2019-12-31
Director/Board Member 62 2019-12-31
Date Insider Type Main position Quantity % Market Cap.
3/31/26 Buy

Chairman

28,135 0.0484%
9/24/25 Sell

Chief Financial Officer

29,500 0.0508%
9/24/25 Sell

Chief Financial Officer

16,700 0.0287%
Change 5-day change 1-year change 3-year change Capi.($)
+0.85%+1.37%-13.03%+213.29% 1.72B
+0.24%+0.47%+37.06%+4.80% 12.57B
-0.85%-1.93%+15.32%+15.79% 6.45B
+0.59%+1.25%+48.87%+23.49% 5.75B
+4.99%+4.43% - - 4.96B
+0.54%-5.27%-27.28%+22.45% 4.35B
+1.50%-2.77%-24.75%-20.31% 3.98B
-3.51%+6.84%+41.45%-49.81% 1.98B
-3.60%+0.16%+59.34%-4.20% 1.62B
+2.58%-3.86%-28.05%-52.67% 1.21B
Average +0.33%+0.55%+12.10%+16.98% 4.46B
Weighted average by Cap. +0.58%+0.32%+18.94%+12.88%

Financials

2026 *2027 *
Net sales 3.57M 4.06M 3.32M 3.05M 5.73M 389M 5.81M 39.5M 15.43M 192M 15.24M 14.91M 665M 9.14M 10.4M 8.51M 7.82M 14.68M 998M 14.87M 101M 39.52M 493M 39.05M 38.21M 1.7B
Net income -22.17M -25.22M -20.63M -18.95M -35.58M -2.42B -36.05M -245M -95.8M -1.19B -94.66M -92.62M -4.13B -25.65M -29.18M -23.88M -21.93M -41.18M -2.8B -41.72M -284M -111M -1.38B -110M -107M -4.78B
Net Debt -26.74M -30.42M -24.89M -22.86M -42.93M -2.92B -43.49M -296M -116M -1.44B -114M -112M -4.98B -308K -351K -287K -263K -495K -33.62M -501K -3.41M -1.33M -16.6M -1.32M -1.29M -57.37M
Logo Implantica AG
Implantica AG is Lichtenstein-based medical technology Company, whose mission is to provide effective treatment for serious health conditions and to improve patients' life through the use of advanced technologies in the human body, ultimately aiming to reduce costs and increase efficiency in the healthcare System. The therapies developed by Implantica are based on implants that are inserted into the patient's body and remain in the body permanently or semi-permanently to replace bodily functions and/or treat diseases. The Company focuses on the discovery, development and prospective commercialization of medical products and implants that are intended for use in different treatment fields like in the area of gastrointestinal surgery and urology. The Company's lead product is RefluxStop, a passive, implant to prevent gastroesophageal reflux disease (GERD).
Employees
46
Date Price Change Volume
26-07-28 SEK 59.40 +0.85% 3,242
26-07-27 SEK 58.90 +0.17% 16,046
26-07-24 SEK 58.80 -0.34% 5,344
26-07-23 SEK 59.00 0.00% 3,584
26-07-22 SEK 59.00 +0.68% 10,044
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
5.323EUR
Average target price
6.725EUR
Spread / Average Target
+26.33%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IMP A SDB Stock